Monthly use of a real-time continuous glucose monitoring system as an educational and motivational tool for poorly controlled type 1 diabetes adolescents

被引:9
|
作者
Glowinska-Olszewska, B. [1 ]
Tobiaszewska, M. [1 ]
Luczynski, W. [1 ]
Bossowski, A. [1 ]
机构
[1] Med Univ Bialystok, Dept Paediat, Div Cardiol, PL-15274 Bialystok, Poland
来源
ADVANCES IN MEDICAL SCIENCES | 2013年 / 58卷 / 02期
关键词
diabetes type 1; adolescents; real-time continuous glucose monitoring; metabolic control; education; IMPROVED GLYCEMIC CONTROL; SENSOR-AUGMENTED PUMP; PEDIATRIC-PATIENTS; PROLONGED USE; CHILDREN; THERAPY; HYPOGLYCEMIA; VARIABILITY; LIFE;
D O I
10.2478/ams-2013-0024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: Experience with the use of real-time continuous glucose monitoring systems (RT-CGMS) in teenagers with type 1 diabetes mellitus (T1DM) is limited. We aimed to assess the possibility of glycaemic control improvement and to characterize the group of adolescents, who may gain long-term benefits from the use of the RT-CGMS. Methods: Forty T1DM patients, aged 14.6 +/- 2.1 years, with diabetes duration 7.4 +/- 3.6 years and initial HbA(1)c 9.3 +/- 1.5% were recruited. The analysis was based on one-month glucose sensors use, combined with the thorough family support. Patients were analysed in groups according to baseline HbA(1)c: below and above 7.5%, and 10.0%. Comparison between patients with or without improvement in HbA(1)c after 3-month follow-up was also performed. Patients' satisfaction based on the questionnaire was assessed. Results: HbA(1)c level in entire study group decreased after three months, from 9.3 +/- 1.0% to 8.8 +/- 1.6% (P<0.001). In the group with HbA(1)c improvement, reduction was the highest: 9.0 +/- 1.3% vs. 8.0 +/- 1.2% (P<0.001). Only the group with initial HbA(1)c>10% did not achieve significant improvement: 11.2 +/- 0.5% vs. 10.9 +/- 1.1 (P=0.06). In satisfaction questionnaire the lowest scores (negative opinion) were reported by group of patients with initial HbA(1)c above 10%, while the highest scores (positive opinion) were found in the group with improvement of HbA(1)c after 3 month follow-up. Conclusion: Short-term use of CGMS RT, united with satisfaction questionnaire, performed in poorly controlled teenagers with T1DM, can be useful in defining the group of young patients, who can benefit from long-term CGMS RT use in metabolic control improvement.
引用
收藏
页码:344 / 352
页数:9
相关论文
共 50 条
  • [21] Use of Integrated Real-Time Continuous Glucose Monitoring/Insulin Pump System in Children and Adolescents with Type 1 Diabetes: A 3-Year Follow-Up Study
    Scaramuzza, Andrea E.
    Iafusco, Dario
    Rabbone, Ivana
    Bonfanti, Riccardo
    Lombardo, Fortunato
    Schiaffini, Riccardo
    Buono, Pietro
    Toni, Sonia
    Cherubini, Valentino
    Zuccotti, Gian Vincenzo
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (02) : 99 - 103
  • [22] Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives
    Pickup, John C.
    Holloway, Melissa Ford
    Samsi, Kritika
    DIABETES CARE, 2015, 38 (04) : 544 - 550
  • [23] The interrelationship of HbA1c and real-time continuous glucose monitoring in children with type 1 diabetes
    Ferenci, Tamas
    Koerner, Anna
    Kovacs, Levente
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (01) : 38 - 44
  • [24] Real-time continuous glucose monitoring as a tool to prevent severe hypoglycaemia in selected pregnant women with Type 1 diabetes - an observational study
    Secher, A. L.
    Stage, E.
    Ringholm, L.
    Barfred, C.
    Damm, P.
    Mathiesen, E. R.
    DIABETIC MEDICINE, 2014, 31 (03) : 352 - 356
  • [25] Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis
    Benkhadra, Khalid
    Alahdab, Fares
    Tamhane, Shrikant
    Wang, Zhen
    Prokop, Larry J.
    Hirsch, Irl B.
    Raccah, Denis
    Riveline, Jean-Pierre
    Kordonouri, Olga
    Murad, Mohammad Hassan
    CLINICAL ENDOCRINOLOGY, 2017, 86 (03) : 354 - 360
  • [26] Impact of Real-Time Continuous Glucose Monitoring Use on Glucose Variability and Endothelial Function in Adolescents with Type 1 Diabetes: New Technology-New Possibility to Decrease Cardiovascular Risk?
    Jamiolkowska, Milena
    Jamiolkowska, Izabela
    Lucznski, Wlodzimierz
    Tolwinska, Joanna
    Bossowski, Artur
    Olszewska, Barbara Glowinska
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [27] Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study
    Urakami, Tatsuhiko
    Terada, Hiroki
    Yoshida, Kei
    Kuwabara, Remi
    Mine, Yusuke
    Aoki, Masako
    Shoji, Yasuko
    Suzuki, Junichi
    Morioka, Ichiro
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (10) : 1745 - 1752
  • [28] Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes
    Slover, Robert H.
    Tryggestad, Jeanie B.
    DiMeglio, Linda A.
    Fox, Larry A.
    Bode, Bruce W.
    Bailey, Timothy S.
    Brazg, Ronald
    Christiansen, Mark P.
    Sherr, Jennifer L.
    Tsalikian, Eva
    Kaiserman, Kevin B.
    Sullivan, Ashley
    Huang, Suiying
    Shin, John
    Lee, Scott W.
    Kaufman, Francine R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (09) : 576 - 584
  • [29] Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes
    Norgaard, Sidse Kjaerhus
    Mathiesen, Elisabeth Reinhardt
    Norgaard, Kirsten
    Ringholm, Lene
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (10) : 665 - 672
  • [30] Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes
    Zaharieva, Dessi P.
    Turksoy, Kamuran
    McGaugh, Sarah M.
    Pooni, Rubin
    Vienneau, Todd
    Ly, Trang
    Riddell, Michael C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (06) : 313 - 321